NCT07617272
Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@genomenon.com

NCT ID NCT07617272
Title Prostate Androgen Response Investigation Using a Stratification BIOmarker; Predicting Prostate Cancer Downstaging by Neoadjuvant Darolutamide With PCAI ImmunoScore (PARIS-BIO)
Acronym PARIS-BIO
Recruitment Recruiting
Gender male
Phase Phase II
Variant Requirements No
Sponsors Region Stockholm
Indications
Therapies
Age Groups: adult | senior
Covered Countries SWE


No variant requirements are available.